Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ·Healthcare·Biotechnology
$813.61
+0.74%
Mkt Cap $83.15B
Analyst Ratings
Buy
23
Hold
7
Sell
0
Price Target (145 analysts)
$827.71
Range $730.00 – $1,030.00
Implied Upside
+1.7%
Consensus $827.71 vs current $813.61